-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical Network, July 21.
In the first half of this year, the production of four new crown vaccines led by Beijing accounted for about 90% of the country; two were produced by Sinopharm Beijing Institute of Biological Products and Beijing Kexing Zhongwei Biotechnology Co.
, Ltd.
The cumulative output value of vaccines exceeded 120 billion yuan (RMB, the same below), driving the added value of the pharmaceutical manufacturing industry to increase by 2.
9 times, an average growth rate of 94.
2% in two years
.
The vaccine industry has not only contributed Beijing's strength to the fight against the epidemic, but has also become a nuclear explosion that supports the rapid growth of the industry
.
In the first half of this year, the production of four new crown vaccines led by Beijing accounted for about 90% of the country; two were produced by Sinopharm Beijing Institute of Biological Products and Beijing Kexing Zhongwei Biotechnology Co.
, Ltd.
The cumulative output value of vaccines exceeded 120 billion yuan (RMB, the same below), driving the added value of the pharmaceutical manufacturing industry to increase by 2.
9 times, an average growth rate of 94.
2% in two years
.
The vaccine industry has not only contributed Beijing's strength to the fight against the epidemic, but has also become a nuclear explosion that supports the rapid growth of the industry
.
The above was introduced by the relevant person in charge of the Beijing Municipal Development and Reform Commission at the media interpretation meeting held on the 20th
.
In the first half of 2021, Beijing's economic performance was stable and improving.
In the first half of 2021, GDP grew by 13.
4% year-on-year, 0.
7 percentage points higher than the national level
.
.
In the first half of 2021, Beijing's economic performance was stable and improving.
In the first half of 2021, GDP grew by 13.
4% year-on-year, 0.
7 percentage points higher than the national level
.
In the first half of this year, the value added of the industrial enterprises above designated size in Beijing increased by 41.
4% year-on-year, and the two-year average growth rate was 16.
7%, which was 25.
5 and 9.
7% higher than the national level respectively
.
Among them, the lead of the vaccine industry is very eye-catching
.
4% year-on-year, and the two-year average growth rate was 16.
7%, which was 25.
5 and 9.
7% higher than the national level respectively
.
Among them, the lead of the vaccine industry is very eye-catching
.
As of 12:00 on July 20, the coverage rate of the new crown vaccine for people aged 18 and over in Beijing reached 90.
61%
.
Four vaccines have been approved for conditional listing or emergency use in China, and the output accounts for about 90% of the country.
The cumulative output value of the two vaccines produced by Sinopharm Beijing Institute of Biological Products and Beijing Kexing Zhongwei Biotechnology Co.
, Ltd.
exceeded 120 billion The value added of the pharmaceutical manufacturing industry increased by 2.
9 times, an average growth rate of 94.
2% in two years
.
61%
.
Four vaccines have been approved for conditional listing or emergency use in China, and the output accounts for about 90% of the country.
The cumulative output value of the two vaccines produced by Sinopharm Beijing Institute of Biological Products and Beijing Kexing Zhongwei Biotechnology Co.
, Ltd.
exceeded 120 billion The value added of the pharmaceutical manufacturing industry increased by 2.
9 times, an average growth rate of 94.
2% in two years
.
In the first half of this year, Beijing saw new results in the construction of high-precision economic structure, new adjustments in the demand structure, and a new look in the distribution of productivity
.
.
In addition to the vaccine industry, in the first half of the year, the added value of Beijing's electronics industry increased by 25.
7% year-on-year, and the two-year average growth was 20.
3%; the high-tech manufacturing and strategic emerging industries increased by 54.
4% and 42.
8% respectively in the two-year average, leading high-end companies This feature is more prominent; the added value of the information service industry and the financial industry increased by 17.
2% and 5% year-on-year respectively.
In the first half of the year , there were 37 new listed companies , of which 9 were listed on the Science and Technology Innovation Board, and the industry's supporting role was more obvious
.
(Finish)
7% year-on-year, and the two-year average growth was 20.
3%; the high-tech manufacturing and strategic emerging industries increased by 54.
4% and 42.
8% respectively in the two-year average, leading high-end companies This feature is more prominent; the added value of the information service industry and the financial industry increased by 17.
2% and 5% year-on-year respectively.
In the first half of the year , there were 37 new listed companies , of which 9 were listed on the Science and Technology Innovation Board, and the industry's supporting role was more obvious
.
(Finish)
Medical Network, July 21.
In the first half of this year, the production of four new crown vaccines led by Beijing accounted for about 90% of the country; two were produced by Sinopharm Beijing Institute of Biological Products and Beijing Kexing Zhongwei Biotechnology Co.
, Ltd.
The cumulative output value of vaccines exceeded 120 billion yuan (RMB, the same below), driving the added value of the pharmaceutical manufacturing industry to increase by 2.
9 times, an average growth rate of 94.
2% in two years
.
The vaccine industry has not only contributed Beijing's strength to the fight against the epidemic, but has also become a nuclear explosion that supports the rapid growth of the industry
.
In the first half of this year, the production of four new crown vaccines led by Beijing accounted for about 90% of the country; two were produced by Sinopharm Beijing Institute of Biological Products and Beijing Kexing Zhongwei Biotechnology Co.
, Ltd.
The cumulative output value of vaccines exceeded 120 billion yuan (RMB, the same below), driving the added value of the pharmaceutical manufacturing industry to increase by 2.
9 times, an average growth rate of 94.
2% in two years
.
The vaccine industry has not only contributed Beijing's strength to the fight against the epidemic, but has also become a nuclear explosion that supports the rapid growth of the industry
.
The above was introduced by the relevant person in charge of the Beijing Municipal Development and Reform Commission at the media interpretation meeting held on the 20th
.
In the first half of 2021, Beijing's economic performance was stable and improving.
In the first half of 2021, GDP grew by 13.
4% year-on-year, 0.
7 percentage points higher than the national level
.
.
In the first half of 2021, Beijing's economic performance was stable and improving.
In the first half of 2021, GDP grew by 13.
4% year-on-year, 0.
7 percentage points higher than the national level
.
In the first half of this year, the value added of the industrial enterprises above designated size in Beijing increased by 41.
4% year-on-year, and the two-year average growth rate was 16.
7%, which was 25.
5 and 9.
7% higher than the national level respectively
.
Among them, the lead of the vaccine industry is very eye-catching
.
4% year-on-year, and the two-year average growth rate was 16.
7%, which was 25.
5 and 9.
7% higher than the national level respectively
.
Among them, the lead of the vaccine industry is very eye-catching
.
As of 12:00 on July 20, the coverage rate of the new crown vaccine for people aged 18 and over in Beijing reached 90.
61%
.
Four vaccines have been approved for conditional listing or emergency use in China, and the output accounts for about 90% of the country.
The cumulative output value of the two vaccines produced by Sinopharm Beijing Institute of Biological Products and Beijing Kexing Zhongwei Biotechnology Co.
, Ltd.
exceeded 120 billion The value added of the pharmaceutical manufacturing industry increased by 2.
9 times, an average growth rate of 94.
2% in two years
.
61%
.
Four vaccines have been approved for conditional listing or emergency use in China, and the output accounts for about 90% of the country.
The cumulative output value of the two vaccines produced by Sinopharm Beijing Institute of Biological Products and Beijing Kexing Zhongwei Biotechnology Co.
, Ltd.
exceeded 120 billion The value added of the pharmaceutical manufacturing industry increased by 2.
9 times, an average growth rate of 94.
2% in two years
.
In the first half of this year, Beijing saw new results in the construction of high-precision economic structure, new adjustments in the demand structure, and a new look in the distribution of productivity
.
.
In addition to the vaccine industry, in the first half of the year, the added value of Beijing's electronics industry increased by 25.
7% year-on-year, and the two-year average growth was 20.
3%; the high-tech manufacturing and strategic emerging industries increased by 54.
4% and 42.
8% respectively in the two-year average, leading high-end companies This feature is more prominent; the added value of the information service industry and the financial industry increased by 17.
2% and 5% year-on-year respectively.
In the first half of the year , there were 37 new listed companies , of which 9 were listed on the Science and Technology Innovation Board, and the industry's supporting role was more obvious
.
(Finish)
7% year-on-year, and the two-year average growth was 20.
3%; the high-tech manufacturing and strategic emerging industries increased by 54.
4% and 42.
8% respectively in the two-year average, leading high-end companies This feature is more prominent; the added value of the information service industry and the financial industry increased by 17.
2% and 5% year-on-year respectively.
In the first half of the year , there were 37 new listed companies , of which 9 were listed on the Science and Technology Innovation Board, and the industry's supporting role was more obvious
.
(Finish)
Medical Network, July 21.
In the first half of this year, the production of four new crown vaccines led by Beijing accounted for about 90% of the country; two were produced by Sinopharm Beijing Institute of Biological Products and Beijing Kexing Zhongwei Biotechnology Co.
, Ltd.
The cumulative output value of vaccines exceeded 120 billion yuan (RMB, the same below), driving the added value of the pharmaceutical manufacturing industry to increase by 2.
9 times, an average growth rate of 94.
2% in two years
.
The vaccine industry has not only contributed Beijing's strength to the fight against the epidemic, but has also become a nuclear explosion that supports the rapid growth of the industry
.
In the first half of this year, the production of four new crown vaccines led by Beijing accounted for about 90% of the country; two were produced by Sinopharm Beijing Institute of Biological Products and Beijing Kexing Zhongwei Biotechnology Co.
, Ltd.
The cumulative output value of vaccines exceeded 120 billion yuan (RMB, the same below), driving the added value of the pharmaceutical manufacturing industry to increase by 2.
9 times, an average growth rate of 94.
2% in two years
.
The vaccine industry has not only contributed Beijing's strength to the fight against the epidemic, but has also become a nuclear explosion that supports the rapid growth of the industry
.
The above was introduced by the relevant person in charge of the Beijing Municipal Development and Reform Commission at the media interpretation meeting held on the 20th
.
In the first half of 2021, Beijing's economic performance was stable and improving.
In the first half of 2021, GDP grew by 13.
4% year-on-year, 0.
7 percentage points higher than the national level
.
.
In the first half of 2021, Beijing's economic performance was stable and improving.
In the first half of 2021, GDP grew by 13.
4% year-on-year, 0.
7 percentage points higher than the national level
.
In the first half of this year, the value added of the industrial enterprises above designated size in Beijing increased by 41.
4% year-on-year, and the two-year average growth rate was 16.
7%, which was 25.
5 and 9.
7% higher than the national level respectively
.
Among them, the lead of the vaccine industry is very eye-catching
.
4% year-on-year, and the two-year average growth rate was 16.
7%, which was 25.
5 and 9.
7% higher than the national level respectively
.
Among them, the lead of the vaccine industry is very eye-catching
.
As of 12:00 on July 20, the coverage rate of the new crown vaccine for people aged 18 and over in Beijing reached 90.
61%
.
Four vaccines have been approved for conditional listing or emergency use in China, and the output accounts for about 90% of the country.
The cumulative output value of the two vaccines produced by Sinopharm Beijing Institute of Biological Products and Beijing Kexing Zhongwei Biotechnology Co.
, Ltd.
exceeded 120 billion The value added of the pharmaceutical manufacturing industry increased by 2.
9 times, an average growth rate of 94.
2% in two years
.
Medicine Medicine Medicine61%
.
Four vaccines have been approved for conditional listing or emergency use in China, and the output accounts for about 90% of the country.
The cumulative output value of the two vaccines produced by Sinopharm Beijing Institute of Biological Products and Beijing Kexing Zhongwei Biotechnology Co.
, Ltd.
exceeded 120 billion The value added of the pharmaceutical manufacturing industry increased by 2.
9 times, an average growth rate of 94.
2% in two years
.
In the first half of this year, Beijing saw new results in the construction of high-precision economic structure, new adjustments in the demand structure, and a new look in the distribution of productivity
.
.
In addition to the vaccine industry, in the first half of the year, the added value of Beijing's electronics industry increased by 25.
7% year-on-year, and the two-year average growth was 20.
3%; the high-tech manufacturing and strategic emerging industries increased by 54.
4% and 42.
8% respectively in the two-year average, leading high-end companies This feature is more prominent; the added value of the information service industry and the financial industry increased by 17.
2% and 5% year-on-year respectively.
In the first half of the year , there were 37 new listed companies , of which 9 were listed on the Science and Technology Innovation Board, and the industry's supporting role was more obvious
.
(Finish)
Enterprise business enterprise 7% year-on-year, and the two-year average growth was 20.
3%; the high-tech manufacturing and strategic emerging industries increased by 54.
4% and 42.
8% respectively in the two-year average, leading high-end companies This feature is more prominent; the added value of the information service industry and the financial industry increased by 17.
2% and 5% year-on-year respectively.
In the first half of the year , there were 37 new listed companies , of which 9 were listed on the Science and Technology Innovation Board, and the industry's supporting role was more obvious
.
(Finish)
